"This news provides further corroboration that our oral antiviral candidate, if authorized or approved, could have a meaningful impact on the lives of many, as the data further support the efficacy of Paxlovid in reducing hospitalization and death and show a substantial decrease in viral load," Albert Bourla, chairman and CEO of"This underscores the treatment candidate's potential to save the lives of patients around the world.
Pfizer's results also pointed to success against the new Omicron variant, as Paxlovid is seemingly able to target a protein associated with the strain called 3CL, and inhibit replication of the virus. Pfizer announced Tuesday that final studies of their COVID-19 pill show an 89 percent efficacy of reducing hospitalization and death. Here, a Pfizer sign is seen on July 22, 2020 in New York City.Pfizer's study results have so far been shared with the FDA, but have not yet been reviewed by outside scientists. If approved for use, the drug treatment would consist of three pills taken twice a day for a period of five days, according to Politico.
Has this been properly tested and cleared by Joe Rogan ?
😍😍🤩🤩🤩🤩🤩🤩😍😍😍
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer's Covid-19 pill cut risk of hospitalization and death by 89 percent, final results showPfizer's antiviral Covid-19 pill reduced the risk of hospitalization or death by 89 percent in high-risk patients who’d been experiencing symptoms for three days or less It happens in a state running by Democrats whose agenda is to stop ClimateCrisis. so we’ll know to use the pill after we recover naturally after 3 days lol That's the consequence of alliance with the United States.
Source: politico - 🏆 381. / 59 Read more »
Pfizer: Final data on pills to treat Covid-19 holds strong against hospitalization and deathPfizer's updated results for its experimental treatment for Covid-19 showed it cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms, the company announced in a news release Tuesday. Focus should have been early treatment from the beginning Em resumo: Vacina salva vida! Strange that the virus doesn’t effect the same amount of people and a higher 98.6% success rate. Big pharma owns your news network. You couldn’t say otherwise if you wanted.
Source: cnnbrk - 🏆 393. / 55 Read more »
Pfizer confirms COVID pill's results, potency versus omicronPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. Separate laboratory testing shows the drug retains its potency against the omicron variant, the company announced, as many experts had predicted. Pfizer tested the antiviral drug against a man-made version of a key protein that omicron uses to reproduce itself.
Source: YahooNews - 🏆 380. / 59 Read more »
Pfizer says COVID-19 pill near 90% effective in final analysisPfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. 😆😆😆🖕🖕🖕
Source: Reuters - 🏆 2. / 97 Read more »
NPR Cookie Consent and Choices
Source: NPRHealth - 🏆 144. / 63 Read more »
NPR Cookie Consent and Choices
Source: NPRHealth - 🏆 144. / 63 Read more »